Relmada Therapeutics (RLMD) null Earnings

26MarConfirmed
May 19
Sep 19
Nov 19
Mar 20
-0.5
-0.33
-0.17
0

Details

Expected EPS
-0.36
Actual EPS
-0.39
Surprise EPS
-0.03
Surprise Percent
+8.33%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.39 per share for .

0 Comments

Share your thoughts